
Results in Engineering, Год журнала: 2025, Номер unknown, С. 105047 - 105047
Опубликована: Апрель 1, 2025
Язык: Английский
Results in Engineering, Год журнала: 2025, Номер unknown, С. 105047 - 105047
Опубликована: Апрель 1, 2025
Язык: Английский
Diagnostics, Год журнала: 2025, Номер 15(3), С. 397 - 397
Опубликована: Фев. 6, 2025
Radioimmunotherapy (RIT) is a novel cancer treatment that combines radiotherapy and immunotherapy to precisely target tumor antigens using monoclonal antibodies conjugated with radioactive isotopes. This approach offers personalized, systemic, durable treatment, making it effective in cancers resistant conventional therapies. Advances artificial intelligence (AI) present opportunities enhance RIT by improving precision, efficiency, personalization. AI plays critical role patient selection, planning, dosimetry, response assessment, while also contributing drug design classification. review explores the integration of into RIT, emphasizing its potential optimize entire process advance personalized care.
Язык: Английский
Процитировано
3Results in Engineering, Год журнала: 2025, Номер unknown, С. 105047 - 105047
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0